skip to content
Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements, Volume 1: Main Report Preview this item
ClosePreview this item
Checking...

Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements, Volume 1: Main Report

Author: Thomas P FrazierMaria BorgaJohn W BaileyAlec W SalernoJohn J CloosAll authors
Publisher: Ft. Belvoir Defense Technical Information Center OCT 2000.
Edition/Format:   eBook : EnglishView all editions and formats
Database:WorldCat
Summary:
A series of technical problems has delayed FDA approval for BioPort Corporation to deliver anthrax vaccine adsorbed (AVA) to the DoD. BioPort is preparing for a new FDA review, and the DoD is providing both financial relief and technical assistance to augment BioPort's efforts. Under this strategy, the earliest BioPort could gain FDA approval and resume AVA delivery is late May 2001. A more realistic expectation is  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Internet resource
Document Type: Internet Resource
All Authors / Contributors: Thomas P Frazier; Maria Borga; John W Bailey; Alec W Salerno; John J Cloos; INSTITUTE FOR DEFENSE ANALYSES ALEXANDRIA VA.
OCLC Number: 227952060
Notes: Prepared in cooperation with Rand Corporation.
Description: 43 pages

Abstract:

A series of technical problems has delayed FDA approval for BioPort Corporation to deliver anthrax vaccine adsorbed (AVA) to the DoD. BioPort is preparing for a new FDA review, and the DoD is providing both financial relief and technical assistance to augment BioPort's efforts. Under this strategy, the earliest BioPort could gain FDA approval and resume AVA delivery is late May 2001. A more realistic expectation is delivery in the first half of 2002. IDA and the RAND Corporation studied the advantages and disadvantages of the DoD purchasing BioPort's Lansing, Michigan, AVA-production facility and converting it to a government-owned, contractor-operated (GOCO) operation. In one scenario, the DoD would select a new company to run the facility; in another, the DoD would have BioPort run the facility. We found that neither Option would result in vaccine being delivered faster than under the current strategy. Under the first GOCO scenario, the earliest AVA could be delivered would be 2003 (more probably late 2004). Under the second scenario, the earliest delivery date would be August 2001 (more probably late 2002). This report is the first of two volumes.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/227952060> # Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements, Volume 1: Main Report
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "227952060" ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/2979642801#Place/ft_belvoir> ; # Ft. Belvoir
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/vau> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/united_states_government> ; # United states government
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/scenarios> ; # Scenarios
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/anthrax> ; # Anthrax
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Thing/ava_anthrax_vaccine_adsorbed> ; # AVA(ANTHRAX VACCINE ADSORBED)
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/pharmacology> ; # Pharmacology
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/timeliness> ; # Timeliness
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/cost_analysis> ; # Cost analysis
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/industrial_production> ; # Industrial production
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Thing/goco_government_owned_contractor_operated> ; # GOCO(GOVERNMENT OWNED CONTRACTOR OPERATED)
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/mfg_&_industrial_eng_&_control_of_product_sys> ; # Mfg & Industrial Eng & Control of Product Sys
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/bacillus_anthracis> ; # Bacillus anthracis
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/vaccines> ; # Vaccines
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Thing/bioport_corporation> ; # BIOPORT CORPORATION
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Topic/contractors> ; # Contractors
   schema:about <http://experiment.worldcat.org/entity/work/data/2979642801#Thing/fda_food_and_drug_administration> ; # FDA(FOOD AND DRUG ADMINISTRATION)
   schema:bookFormat schema:EBook ;
   schema:contributor <http://experiment.worldcat.org/entity/work/data/2979642801#Person/cloos_john_j> ; # John J. Cloos
   schema:contributor <http://viaf.org/viaf/48765783> ; # Alec W. Salerno
   schema:contributor <http://viaf.org/viaf/28147093> ; # Maria Borga
   schema:contributor <http://viaf.org/viaf/204208363> ; # Thomas P. Frazier
   schema:contributor <http://viaf.org/viaf/132161523> ; # INSTITUTE FOR DEFENSE ANALYSES ALEXANDRIA VA.
   schema:contributor <http://experiment.worldcat.org/entity/work/data/2979642801#Person/bailey_john_w> ; # John W. Bailey
   schema:datePublished "OCT 2000" ;
   schema:datePublished "2000" ;
   schema:description "A series of technical problems has delayed FDA approval for BioPort Corporation to deliver anthrax vaccine adsorbed (AVA) to the DoD. BioPort is preparing for a new FDA review, and the DoD is providing both financial relief and technical assistance to augment BioPort's efforts. Under this strategy, the earliest BioPort could gain FDA approval and resume AVA delivery is late May 2001. A more realistic expectation is delivery in the first half of 2002. IDA and the RAND Corporation studied the advantages and disadvantages of the DoD purchasing BioPort's Lansing, Michigan, AVA-production facility and converting it to a government-owned, contractor-operated (GOCO) operation. In one scenario, the DoD would select a new company to run the facility; in another, the DoD would have BioPort run the facility. We found that neither Option would result in vaccine being delivered faster than under the current strategy. Under the first GOCO scenario, the earliest AVA could be delivered would be 2003 (more probably late 2004). Under the second scenario, the earliest delivery date would be August 2001 (more probably late 2002). This report is the first of two volumes."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/2979642801> ;
   schema:inLanguage "en" ;
   schema:name "Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements, Volume 1: Main Report"@en ;
   schema:productID "227952060" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/227952060#PublicationEvent/ft_belvoirdefense_technical_information_centeroct_2000> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/2979642801#Agent/defense_technical_information_center> ; # Defense Technical Information Center
   schema:url <http://handle.dtic.mil/100.2/ADA388211> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/227952060> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2979642801#Agent/defense_technical_information_center> # Defense Technical Information Center
    a bgn:Agent ;
   schema:name "Defense Technical Information Center" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Person/bailey_john_w> # John W. Bailey
    a schema:Person ;
   schema:familyName "Bailey" ;
   schema:givenName "John W." ;
   schema:name "John W. Bailey" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Person/cloos_john_j> # John J. Cloos
    a schema:Person ;
   schema:familyName "Cloos" ;
   schema:givenName "John J." ;
   schema:name "John J. Cloos" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Thing/ava_anthrax_vaccine_adsorbed> # AVA(ANTHRAX VACCINE ADSORBED)
    a schema:Thing ;
   schema:name "AVA(ANTHRAX VACCINE ADSORBED)" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Thing/bioport_corporation> # BIOPORT CORPORATION
    a schema:Thing ;
   schema:name "BIOPORT CORPORATION" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Thing/fda_food_and_drug_administration> # FDA(FOOD AND DRUG ADMINISTRATION)
    a schema:Thing ;
   schema:name "FDA(FOOD AND DRUG ADMINISTRATION)" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Thing/goco_government_owned_contractor_operated> # GOCO(GOVERNMENT OWNED CONTRACTOR OPERATED)
    a schema:Thing ;
   schema:name "GOCO(GOVERNMENT OWNED CONTRACTOR OPERATED)" ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Topic/industrial_production> # Industrial production
    a schema:Intangible ;
   schema:name "Industrial production"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Topic/mfg_&_industrial_eng_&_control_of_product_sys> # Mfg & Industrial Eng & Control of Product Sys
    a schema:Intangible ;
   schema:name "Mfg & Industrial Eng & Control of Product Sys"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2979642801#Topic/united_states_government> # United states government
    a schema:Intangible ;
   schema:name "United states government"@en ;
    .

<http://viaf.org/viaf/132161523> # INSTITUTE FOR DEFENSE ANALYSES ALEXANDRIA VA.
    a schema:Organization ;
   schema:name "INSTITUTE FOR DEFENSE ANALYSES ALEXANDRIA VA." ;
    .

<http://viaf.org/viaf/204208363> # Thomas P. Frazier
    a schema:Person ;
   schema:familyName "Frazier" ;
   schema:givenName "Thomas P." ;
   schema:name "Thomas P. Frazier" ;
    .

<http://viaf.org/viaf/28147093> # Maria Borga
    a schema:Person ;
   schema:familyName "Borga" ;
   schema:givenName "Maria" ;
   schema:name "Maria Borga" ;
    .

<http://viaf.org/viaf/48765783> # Alec W. Salerno
    a schema:Person ;
   schema:familyName "Salerno" ;
   schema:givenName "Alec W." ;
   schema:name "Alec W. Salerno" ;
    .

<http://www.worldcat.org/title/-/oclc/227952060>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/227952060> ; # Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements, Volume 1: Main Report
   schema:dateModified "2016-05-09" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.